These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Mechanisms mediating the diuretic and natriuretic actions of the incretin hormone glucagon-like peptide-1. Crajoinas RO, Oricchio FT, Pessoa TD, Pacheco BP, Lessa LM, Malnic G, Girardi AC. Am J Physiol Renal Physiol; 2011 Aug 07; 301(2):F355-63. PubMed ID: 21593184 [Abstract] [Full Text] [Related]
3. Regulation of Na+/H+ exchanger NHE3 by glucagon-like peptide 1 receptor agonist exendin-4 in renal proximal tubule cells. Carraro-Lacroix LR, Malnic G, Girardi AC. Am J Physiol Renal Physiol; 2009 Dec 07; 297(6):F1647-55. PubMed ID: 19776173 [Abstract] [Full Text] [Related]
4. The peptide-hormone glucagon-like peptide-1 activates cAMP and inhibits growth of breast cancer cells. Ligumsky H, Wolf I, Israeli S, Haimsohn M, Ferber S, Karasik A, Kaufman B, Rubinek T. Breast Cancer Res Treat; 2012 Apr 07; 132(2):449-61. PubMed ID: 21638053 [Abstract] [Full Text] [Related]
5. An albumin-exendin-4 conjugate engages central and peripheral circuits regulating murine energy and glucose homeostasis. Baggio LL, Huang Q, Cao X, Drucker DJ. Gastroenterology; 2008 Apr 07; 134(4):1137-47. PubMed ID: 18313669 [Abstract] [Full Text] [Related]
6. The role of SGK-1 in angiotensin II-mediated sodium reabsorption in human proximal tubular cells. Stevens VA, Saad S, Poronnik P, Fenton-Lee CA, Polhill TS, Pollock CA. Nephrol Dial Transplant; 2008 Jun 07; 23(6):1834-43. PubMed ID: 18238849 [Abstract] [Full Text] [Related]
7. Exendin-4 increases bone mineral density in type 2 diabetic OLETF rats potentially through the down-regulation of SOST/sclerostin in osteocytes. Kim JY, Lee SK, Jo KJ, Song DY, Lim DM, Park KY, Bonewald LF, Kim BJ. Life Sci; 2013 Mar 21; 92(10):533-40. PubMed ID: 23357248 [Abstract] [Full Text] [Related]
8. Primary porcine proximal tubular cells as a model for transepithelial drug transport in human kidney. Schlatter P, Gutmann H, Drewe J. Eur J Pharm Sci; 2006 May 21; 28(1-2):141-54. PubMed ID: 16510270 [Abstract] [Full Text] [Related]
9. Intestinal regulation of urinary sodium excretion and the pathophysiology of diabetic kidney disease: a focus on glucagon-like peptide 1 and dipeptidyl peptidase 4. Vallon V, Docherty NG. Exp Physiol; 2014 Sep 21; 99(9):1140-5. PubMed ID: 25085841 [Abstract] [Full Text] [Related]
10. Natriuretic effect by exendin-4, but not the DPP-4 inhibitor alogliptin, is mediated via the GLP-1 receptor and preserved in obese type 2 diabetic mice. Rieg T, Gerasimova M, Murray F, Masuda T, Tang T, Rose M, Drucker DJ, Vallon V. Am J Physiol Renal Physiol; 2012 Oct 21; 303(7):F963-71. PubMed ID: 22832924 [Abstract] [Full Text] [Related]
11. Glucagon-like peptide-1 and its receptor agonist exendin-4 modulate cholangiocyte adaptive response to cholestasis. Marzioni M, Alpini G, Saccomanno S, Candelaresi C, Venter J, Rychlicki C, Fava G, Francis H, Trozzi L, Glaser S, Benedetti A. Gastroenterology; 2007 Jul 21; 133(1):244-55. PubMed ID: 17631146 [Abstract] [Full Text] [Related]
12. Vesicular monoamine transporter 1 mediates dopamine secretion in rat proximal tubular cells. Maurel A, Spreux-Varoquaux O, Amenta F, Tayebati SK, Tomassoni D, Seguelas MH, Parini A, Pizzinat N. Am J Physiol Renal Physiol; 2007 May 21; 292(5):F1592-8. PubMed ID: 17244889 [Abstract] [Full Text] [Related]
13. Dipeptidyl peptidase IV inhibition downregulates Na+ - H+ exchanger NHE3 in rat renal proximal tubule. Girardi AC, Fukuda LE, Rossoni LV, Malnic G, Rebouças NA. Am J Physiol Renal Physiol; 2008 Feb 21; 294(2):F414-22. PubMed ID: 18077600 [Abstract] [Full Text] [Related]
14. Activation of GLP-1 receptors on vascular smooth muscle cells reduces the autoregulatory response in afferent arterioles and increases renal blood flow. Jensen EP, Poulsen SS, Kissow H, Holstein-Rathlou NH, Deacon CF, Jensen BL, Holst JJ, Sorensen CM. Am J Physiol Renal Physiol; 2015 Apr 15; 308(8):F867-77. PubMed ID: 25656368 [Abstract] [Full Text] [Related]
15. Glucagon-like peptide-1 suppresses advanced glycation end product-induced monocyte chemoattractant protein-1 expression in mesangial cells by reducing advanced glycation end product receptor level. Ishibashi Y, Nishino Y, Matsui T, Takeuchi M, Yamagishi S. Metabolism; 2011 Sep 15; 60(9):1271-7. PubMed ID: 21388644 [Abstract] [Full Text] [Related]
16. Role of glucagon-like peptide-1 and its agonists on early prevention of cardiac remodeling in type 1 diabetic rat hearts. Barakat GM, Nuwayri-Salti N, Kadi LN, Bitar KM, Al-Jaroudi WA, Bikhazi AB. Gen Physiol Biophys; 2011 Mar 15; 30(1):34-44. PubMed ID: 21460410 [Abstract] [Full Text] [Related]
17. Intravitreal injection of exendin-4 analogue protects retinal cells in early diabetic rats. Zhang Y, Zhang J, Wang Q, Lei X, Chu Q, Xu GT, Ye W. Invest Ophthalmol Vis Sci; 2011 Jan 05; 52(1):278-85. PubMed ID: 20688733 [Abstract] [Full Text] [Related]
18. Glucagon-like peptide-1 receptor activation stimulates hepatic lipid oxidation and restores hepatic signalling alteration induced by a high-fat diet in nonalcoholic steatohepatitis. Svegliati-Baroni G, Saccomanno S, Rychlicki C, Agostinelli L, De Minicis S, Candelaresi C, Faraci G, Pacetti D, Vivarelli M, Nicolini D, Garelli P, Casini A, Manco M, Mingrone G, Risaliti A, Frega GN, Benedetti A, Gastaldelli A. Liver Int; 2011 Oct 05; 31(9):1285-97. PubMed ID: 21745271 [Abstract] [Full Text] [Related]
19. Exendin-4 ameliorates renal ischemia-reperfusion injury in the rat. Yang H, Li H, Wang Z, Shi Y, Jiang G, Zeng F. J Surg Res; 2013 Dec 05; 185(2):825-32. PubMed ID: 23890403 [Abstract] [Full Text] [Related]
20. Lack of effect of exendin-4 and glucagon-like peptide-1-(7,36)-amide on insulin action in non-diabetic humans. Vella A, Shah P, Reed AS, Adkins AS, Basu R, Rizza RA. Diabetologia; 2002 Oct 05; 45(10):1410-5. PubMed ID: 12378382 [Abstract] [Full Text] [Related] Page: [Next] [New Search]